Filter
622
Filtered Results: 622
Text search:
pharmaceutical
management
cycle
Featured
Recommendations
55
New Publications
192
Language
Document type
No document type
330
Studies & Reports
110
Guidelines
84
Strategic & Response Plan
39
Manuals
37
Training Material
8
Fact sheets
8
Situation Updates
4
Resource Platforms
2
Countries / Regions
India
35
Global
31
Ethiopia
27
Kenya
26
Uganda
16
South Africa
14
Liberia
11
Nepal
11
Tanzania
11
Western and Central Europe
11
Sierra Leone
10
Nigeria
10
Zambia
9
Namibia
9
Ghana
8
Philippines
8
Rwanda
7
Bangladesh
7
Ukraine
7
Zimbabwe
6
Indonesia
6
Africa
6
South Sudan
5
Syria
5
Myanmar / Burma
5
Congo, Democratic Republic of
4
Cambodia
4
Malawi
4
Lesotho
4
Eastern Europe and Central Asia
4
Senegal
3
Cameroon
3
Eswatini/ Swaziland
3
West and Central Africa
3
South–East Asia Region
3
Eastern Europe
3
Burkina Faso
2
Pakistan
2
Jordan
2
Thailand
2
Mozambique
2
Botswana
2
East and Southern Africa
2
Latin America and the Carribbean
2
Fiji
2
Laos
2
Vietnam
2
Guinea
1
Mali
1
USA
1
Haiti
1
Somalia
1
Iraq
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Central African Republic
1
Brazil
1
Libya
1
Yemen
1
Middle East and North Africa
1
Albania
1
Southern Africa
1
Timor Leste/ East Timor
1
Lithuania
1
Moldova
1
Iran
1
Australia
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
266
Clinical Guidelines
35
Key Resources
31
Public Health
29
Women & Child Health
17
Pharmacy & Technologies
8
Capacity Building
7
Toolboxes
Pharmacy
56
AMR
50
COVID-19
30
HIV
29
Mental Health
28
Planetary Health
27
TB
26
NTDs
25
Rapid Response
17
Conflict
13
NCDs
12
Health Financing Toolbox
11
Caregiver
10
Ebola
9
Global Health Education
8
Specific Hazards
6
Disability
4
Natural Hazards
3
Refugee
3
Social Ethics
2
Health Financing
2
South Sudan
1
Zika
1
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands of human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
This report includes six case studies from 12 individuals with lived experience of diverse health conditions. These case studies explore the topics of power dynamics and power reorientation towards individuals with lived experience; informed decision-making and health literacy; community engagement ...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
A year ago, the second Special Session of the World Health Assembly (WHASS) unanimously agreed to start a diplomatic process for a new binding instrument aimed at ensuring the international community is better prepared for the next health emergencies. The establishment of an Intergovernmental Negoti...
In 2006, the Special Session of African Union Health Ministers adopted the Maputo Plan of Action for implementing the Continental Policy Framework on sexual and reproductive health and rights (SRHR), which expired at the end of 2015. The goal was for all stakeholders and partners to join forces and ...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at high-level United Nations meetings. It highlights ...
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
Towards the Peoples Health Assembly Book - 4
Towards the Peoples Health Assembly Book - 1
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
Towards the Peoples Health Assembly Book -4
The guide helps network managers and technical experts navigate the steps necessary for gathering, structuring, analyzing and reporting information needed to make strategic plans that improve sustainability and equity.
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
